These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 34251499)

  • 1. LncRNA H19 modulated by miR-146b-3p/miR-1539-mediated allelic regulation in transarterial chemoembolization of hepatocellular carcinoma.
    Song Y; Xing H; Zhou L; Zhang N; Yang M
    Arch Toxicol; 2021 Sep; 95(9):3063-3070. PubMed ID: 34251499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Macrophages-induced long noncoding RNA H19 up-regulation triggers and activates the miR-193b/MAPK1 axis and promotes cell aggressiveness in hepatocellular carcinoma.
    Ye Y; Guo J; Xiao P; Ning J; Zhang R; Liu P; Yu W; Xu L; Zhao Y; Yu J
    Cancer Lett; 2020 Jan; 469():310-322. PubMed ID: 31705929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N6-methyladenosine reader YTHDC2 and eraser FTO may determine hepatocellular carcinoma prognoses after transarterial chemoembolization.
    Liu J; Wang D; Zhou J; Wang L; Zhang N; Zhou L; Zeng J; Liu J; Yang M
    Arch Toxicol; 2021 May; 95(5):1621-1629. PubMed ID: 33713148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MiR-125b Loss Activated HIF1α/pAKT Loop, Leading to Transarterial Chemoembolization Resistance in Hepatocellular Carcinoma.
    Wei X; Zhao L; Ren R; Ji F; Xue S; Zhang J; Liu Z; Ma Z; Wang XW; Wong L; Liu N; Shi J; Guo X; Roessler S; Zheng X; Ji J
    Hepatology; 2021 Apr; 73(4):1381-1398. PubMed ID: 32609900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exosomal lncRNA H19 promotes the progression of hepatocellular carcinoma treated with Propofol via miR-520a-3p/LIMK1 axis.
    Wang D; Xing N; Yang T; Liu J; Zhao H; He J; Ai Y; Yang J
    Cancer Med; 2020 Oct; 9(19):7218-7230. PubMed ID: 32767662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LncRNA H19 promotes the development of hepatitis B related hepatocellular carcinoma through regulating microRNA-22 via EMT pathway.
    Li L; Han T; Liu K; Lei CG; Wang ZC; Shi GJ
    Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5392-5401. PubMed ID: 31298392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The LncRNA H19/miR-193a-3p axis modifies the radio-resistance and chemotherapeutic tolerance of hepatocellular carcinoma cells by targeting PSEN1.
    Ma H; Yuan L; Li W; Xu K; Yang L
    J Cell Biochem; 2018 Nov; 119(10):8325-8335. PubMed ID: 29968942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-372-3p Predicts Response of TACE Patients Treated with Doxorubicin and Enhances Chemosensitivity in Hepatocellular Carcinoma.
    Soliman MH; Ragheb MA; Elzayat EM; Mohamed MS; El-Ekiaby N; Abdelaziz AI; Abdel-Wahab AA
    Anticancer Agents Med Chem; 2021; 21(2):246-253. PubMed ID: 32416702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High glucose regulates ERp29 in hepatocellular carcinoma by LncRNA MEG3-miRNA 483-3p pathway.
    Li X; Cheng T; He Y; Zhou S; Wang Y; Zhang K; Yu P
    Life Sci; 2019 Sep; 232():116602. PubMed ID: 31251997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of serum microRNA expression in hepatocellular carcinomas treated with transarterial chemoembolization and patient survival.
    Liu M; Liu J; Wang L; Wu H; Zhou C; Zhu H; Xu N; Xie Y
    PLoS One; 2014; 9(10):e109347. PubMed ID: 25275448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of H19/miR-326 axis in hepatocellular carcinoma development through modulating TWIST1.
    Wei LQ; Li L; Lu C; Liu J; Chen Y; Wu H
    J Cell Physiol; 2019 Apr; 234(4):5153-5162. PubMed ID: 30362512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic Variants in ASCT2 Gene are Associated with the Prognosis of Transarterial Chemoembolisation-Treated Early- Stage Hepatocelluar Carcinoma.
    Ge NJ; Shi ZY; Yu XH; Huang XJ; Wu YS; Chen YY; Zhang J; Yang YF
    Asian Pac J Cancer Prev; 2015; 16(9):4103-7. PubMed ID: 25987094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Possible Use of miR-223-3p as a Prognostic Marker in Transarterial Chemoembolization Treatment of Hepatocellular Carcinoma Patients.
    E Abdelaziz H; El-Guendy N; Radwan EM; Sharawi SK; El-Houseini ME; Abdel-Wahab AA
    Asian Pac J Cancer Prev; 2022 Dec; 23(12):4125-4135. PubMed ID: 36579994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Small regulatory polypeptide of amino acid response negatively relates to poor prognosis and controls hepatocellular carcinoma progression via regulating microRNA-5581-3p/human cardiolipin synthase 1.
    Yin J; Liu Q; Chen C; Liu W
    J Cell Physiol; 2019 Aug; 234(10):17589-17599. PubMed ID: 30825207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LncRNA-H19 activates CDC42/PAK1 pathway to promote cell proliferation, migration and invasion by targeting miR-15b in hepatocellular carcinoma.
    Zhou Y; Fan RG; Qin CL; Jia J; Wu XD; Zha WZ
    Genomics; 2019 Dec; 111(6):1862-1872. PubMed ID: 30543848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-1285-3p acts as a potential tumor suppressor miRNA via downregulating JUN expression in hepatocellular carcinoma.
    Liu J; Yan J; Zhou C; Ma Q; Jin Q; Yang Z
    Tumour Biol; 2015 Jan; 36(1):219-25. PubMed ID: 25230788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival benefit of transarterial chemoembolization in patients with metastatic hepatocellular carcinoma: a single center experience.
    Bettinger D; Spode R; Glaser N; Buettner N; Boettler T; Neumann-Haefelin C; Brunner TB; Gkika E; Maruschke L; Thimme R; Schultheiss M
    BMC Gastroenterol; 2017 Aug; 17(1):98. PubMed ID: 28797231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is Salvage Liver Resection Necessary for Initially Unresectable Hepatocellular Carcinoma Patients Downstaged by Transarterial Chemoembolization? Ten Years of Experience.
    Zhang Y; Huang G; Wang Y; Liang L; Peng B; Fan W; Yang J; Huang Y; Yao W; Li J
    Oncologist; 2016 Dec; 21(12):1442-1449. PubMed ID: 27486202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long noncoding RNA ZFPM2-AS1 acts as a miRNA sponge and promotes cell invasion through regulation of miR-139/GDF10 in hepatocellular carcinoma.
    He H; Wang Y; Ye P; Yi D; Cheng Y; Tang H; Zhu Z; Wang X; Jin S
    J Exp Clin Cancer Res; 2020 Aug; 39(1):159. PubMed ID: 32795316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rs217727 polymorphism in H19 promotes cell apoptosis by regulating the expressions of H19 and the activation of its downstream signaling pathway.
    Ge L; Wang Q; Hu S; Yang X
    J Cell Physiol; 2019 May; 234(5):7279-7291. PubMed ID: 30362559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.